Evidence map›Paper›PMID 17103037›Full record

ArticleDigestive diseases and sciences2006

Clostridium difficile-associated pouchitis.

Bo Shen, John R Goldblum, Tracy L Hull, Feza H Remzi, Ana E Bennett, Victor W Fazio

Registry-linked trialAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00583076 (A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00583076 phase2completednot on this mapstarted 2007, after this paper: background citation

A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis

TypeinterventionalSponsorOcera TherapeuticsRan2007 to 2008Enrolled19ConditionsPouchitisArmsAST-120
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Fecal microbiota transplantation forGastroenterology report · 2017
    Article
  6. Clostridium difficile infection: risk factors, diagnosis and management.Current treatment options in gastroenterology · 2015
    Article
  7. Article
  8. Review
  9. Innate immune environment in ileal pouch mucosa: α5 defensin up-regulation as predictor of chronic/relapsing pouchitis.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2012
    Article
  10. Article
  11. Article
  12. Fulminant Clostridium difficile-associated pouchitis with a fatal outcome.Nature reviews. Gastroenterology & hepatology · 2009
    Review
  13. Article
  14. Article
  15. Diagnosis and treatment of pouchitis.Gastroenterology & hepatology · 2008
    Article
  16. Catastrophic Clostridium difficile enteritis in a pelvic pouch patient: report of a case.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2008
    Article
  17. Review
  18. Pouchitis.World journal of gastroenterology · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bo ShenCenter for Inflammatory Bowel Disease, Departments of Gastroenterology/Hepatology-Desk A30, The Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195, USA. shenb@ccf.org
John R Goldblum
Tracy L Hull
Feza H Remzi
Ana E Bennett
Victor W Fazio
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pouchitis is the most common long-term sequela of ileal pouch-anal anastomosis (IPAA) following total proctocolectomy. No single pathogen is identified as being solely responsible for the pathogenesis of the disease. Here we describe a case of Clostridium difficile-associated pouchitis that was successfully treated with ciprofloxacin and tinidazole. Diagnosis and management of a patient with medically refractory pouchitis associated with Clostridium difficile infection is described. A 63-year-old male with underlying ulcerative colitis and IPAA presented with increased stool frequency and seepage for 2 months, which partially responded to oral metronidazole. While on the antibiotic therapy, pouch endoscopy was performed and showed severe pouchitis. Assays for Clostridium difficile toxins in stool specimens were positive. He was treated with a 4-week course of ciprofloxacin 500 mg BID and tinidazole 500 mg TID. His symptoms resolved within several days from the initiation of therapy. A repeat pouch endoscopy at week 5 showed a complete resolution of mucosal inflammation of the pouch, while tests for Clostridium difficile toxins became negative. Clostridium difficile-associated pouchitis is rare. However, Clostridium difficile infection should be excluded in patients with chronic refractory pouchitis.

Indexed as

Anti-Infective AgentsCiprofloxacinClostridioides difficileEnterocolitis, PseudomembranousHumansMaleMiddle AgedPouchitisTinidazoleAnti-Infective AgentsCiprofloxacinTinidazole

Identifiers

PMID17103037
OpenAlexW2007104347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.